Alnylam Pharmaceuticals, Inc.
ALNY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,490,249 | $1,113,685 | $1,019,654 | $966,428 |
| Short-Term Investments | $1,234,375 | $1,743,900 | $1,612,568 | $1,728,076 |
| Receivables | $964,768 | $567,112 | $418,035 | $405,308 |
| Inventory | $75,383 | $71,688 | $65,581 | $78,509 |
| Other Curr. Assets | $188,036 | $147,314 | $152,420 | $116,964 |
| Total Curr. Assets | $3,952,811 | $3,643,699 | $3,268,258 | $3,295,285 |
| Property Plant & Equip (Net) | $693,144 | $692,192 | $695,917 | $693,932 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $53,867 | $0 | $0 | $0 |
| Tax Assets | $98,558 | $104,363 | $107,224 | $116,863 |
| Other NC Assets | $53,282 | $125,765 | $142,412 | $133,903 |
| Total NC Assets | $898,851 | $922,320 | $945,553 | $944,698 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,851,662 | $4,566,019 | $4,213,811 | $4,239,983 |
| Liabilities | – | – | – | – |
| Payables | $117,591 | $102,393 | $97,399 | $88,415 |
| Short-Term Debt | $160,446 | $97,523 | $81,793 | $113,018 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2,541 | $15,080 | $28,160 | $55,481 |
| Other Curr. Liab. | $1,274,899 | $120,788 | $118,095 | $214,399 |
| Total Curr. Liab. | $1,555,477 | $1,300,847 | $1,075,623 | $1,186,272 |
| LT Debt | $2,389,442 | $2,371,669 | $2,364,387 | $2,358,974 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $449,428 | $418,467 | $428,305 | $398,108 |
| Total NC Liab. | $3,062,291 | $3,014,581 | $3,022,753 | $2,986,623 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $268,176 | $270,542 | $276,072 | $271,427 |
| Total Liabilities | $4,617,768 | $4,315,428 | $4,098,376 | $4,172,895 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,318 | $1,310 | $1,303 | $1,293 |
| Retained Earnings | -$7,160,420 | -$7,411,504 | -$7,345,227 | -$7,287,748 |
| AOCI | -$21,775 | -$29,952 | -$37,517 | -$34,518 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $233,894 | $250,591 | $115,435 | $67,088 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,851,662 | $4,566,019 | $4,213,811 | $4,239,983 |
| Net Debt | $1,059,639 | $1,355,507 | $1,426,526 | $1,505,564 |